Bio-Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030

Bio-Imaging Trends and Forecast

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030 with a CAGR of 15.7% from 2024 to 2030. The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging by type, technology, end use, and region.

Bio-Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Elastography
• Magnetic Resonance Imaging
• Medical Ultrasonography or Ultrasound
• X-Ray Radiography

Bio-Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Medical
• Molecular

Bio-Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Diagnostic Centers
• Hospitals
• Laboratories

Bio-Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

• Bioclinica
• Bracco Imaging
• Fonar
• Bayer Healthcare Pharmaceuticals
• Covidin
• GE Healthcare
• Gammamedica

Bio-Imaging Market Insights

• Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.

• Within this market, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enables hospitals to streamline their operations.

• North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Features of the Global Bio-Imaging Market

• Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region. in terms of value ($B).

• Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and region.s for the bio-imaging market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the bio-imaging market size?

Answer: The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030.

Q.2. What is the growth forecast for bio-imaging market?

Answer: The global bio-imaging market is expected to grow with a CAGR of 15.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the bio-imaging market?

Answer: The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

Q.4. What are the major segments for bio-imaging market?

Answer: The future of the bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets.

Q.5. Who are the key bio-imaging market companies?

Answer: Some of the key bio-imaging companies are as follows:

• Bioclinica
• Bracco Imaging
• Fonar
• Bayer Healthcare Pharmaceuticals
• Covidin
• GE Healthcare
• Gammamedica

Q.6. Which bio-imaging market segment will be the largest in future?

Answer: Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.

Q.7. In bio-imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?